시장보고서
상품코드
1181651

세계의 전자 피부 패치 시장 : 전망과 예측(2022-2027년)

Electronic Skin Patches Market - Global Outlook & Forecast 2022-2027

발행일: | 리서치사: Arizton Advisory & Intelligence | 페이지 정보: 영문 268 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 전자 피부 패치 시장 규모는 2022-2027년에 CAGR로 20.17%의 성장이 예측됩니다.

세계의 전자 피부 패치 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인, 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 조사 목적

제3장 조사 프로세스

제4장 범위

제5장 리포트 전제조건과 주의사항

제6장 시장의 개요

제7장 주요 인사이트

  • 세계의 전자 피부 패치 시장

제8장 서론

제9장 시장 기회와 동향

제10장 시장 성장 촉진요인

제11장 시장 성장 억제요인

제12장 시장 구도

  • 시장의 개요
  • 시장 규모와 예측
    • 인사이트 : 용도별
    • 인사이트 : 최종사용자별
    • 인사이트 : 지역별
  • Five forces 분석

제13장 용도

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 당뇨병 관리
  • 종합 환자 모니터링
  • 심혈관 모니터링
  • 기타

제14장 최종사용자

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 홈케어 환경
  • 병원
  • 진료소, 전문 진료소
  • 기타

제15장 지역

  • 시장 스냅숏과 성장 엔진
  • 지역적 개요

제16장 북미

  • 시장의 개요
  • 시장 규모와 예측
    • 북미 : 용도
    • 북미 : 최종사용자
  • 주요 국가
    • 미국 : 시장 규모와 예측
    • 캐나다 : 시장 규모와 예측

제17장 유럽

  • 시장의 개요
  • 시장 규모와 예측
    • 유럽 : 용도
    • 유럽 : 최종사용자
  • 주요 국가
    • 독일 : 시장 규모와 예측
    • 프랑스 : 시장 규모와 예측
    • 영국 : 시장 규모와 예측
    • 이탈리아 : 시장 규모와 예측
    • 스페인 : 시장 규모와 예측

제18장 아시아태평양

  • 시장의 개요
  • 시장 규모와 예측
    • 아시아태평양 : 용도
    • 아시아태평양 : 최종사용자
  • 주요 국가
    • 일본 : 시장 규모와 예측
    • 중국 : 시장 규모와 예측
    • 인도 : 시장 규모와 예측
    • 한국 : 시장 규모와 예측
    • 호주 : 시장 규모와 예측

제19장 라틴아메리카

  • 시장의 개요
  • 시장 규모와 예측
    • 라틴아메리카 : 용도
    • 라틴아메리카 : 최종사용자
  • 주요 국가
    • 브라질 : 시장 규모와 예측
    • 멕시코 : 시장 규모와 예측
    • 아르헨티나 : 시장 규모와 예측

제20장 중동·아프리카

  • 시장의 개요
  • 시장 규모와 예측
    • 중동·아프리카 : 용도
    • 중동·아프리카 : 최종사용자
  • 주요 국가
    • 터키 : 시장 규모와 예측
    • 남아프리카공화국 : 시장 규모와 예측
    • 사우디아라비아 : 시장 규모와 예측

제21장 경쟁 구도

  • 경쟁의 개요
  • 시장 점유율 분석

제22장 주요 기업 개요

  • ABBOTT
  • DEXCOM
  • GENERAL ELECTRIC COMPANY
  • KONINKLIJKE PHILIPS N.V.

제23장 기타 유명 벤더

  • A. MENARINI DIAGNOSTICS
  • BARDY DIAGNOSTICS
  • BENWARE MEDICAL
  • BITTIUM
  • BLOOMLIFE
  • BLUE SPARK TECHNOLOGIES
  • BORSAM BIOMEDICAL INSTRUMENTS CO.
  • BOSTON SCIENTIFIC
  • CARDIOMO
  • DMS-SERVICE
  • EPICORE BIOSYSTEMS
  • FUKUDA DENSHI
  • GAMASTECH
  • HOLST CENTRE
  • INSULET
  • IRHYTHM TECHNOLOGIES
  • ISANSYS
  • LCR HALLCREST
  • LIFESIGNALS
  • LIV APS
  • MEDICOMP
  • MEDIDATA
  • MEDICSENSORS S.L
  • MEDTRUM TECHNOLOGIES
  • NATURES FREQUENCIES
  • NEMURA MEDICAL
  • OMRON HEALTHCARE
  • ONERA TECHNOLOGIES B.V.
  • PAINMASTER
  • QT MEDICAL
  • QUAD INDUSTRIES
  • SMITH+NEPHEW
  • SPOTSEE
  • THE SURGICAL COMPANY
  • THERANICA BIO-ELECTRONICS
  • THE SCOTT FETZER COMPANY
  • VIRILITY MEDICAL
  • VITAL CONNECT
  • VIVALNK
  • VIVOMI
  • WEAROPTIMO
  • XSENSIO

제24장 리포트 요약

  • 주요 사항
  • 전략적 권장사항

제25장 정량적 요약

제26장 부록

KSA 23.01.19

The global electronic skin patches market is expected to grow at a CAGR of 20.17% during 2022-2027.

MARKET INSIGHTS

  • The significant factors contributing to the growth of the electronic skin patches market include the rise in the need for continuous monitoring of physiological parameters, growing penetration of wearable devices and mobile platforms for healthcare monitoring, development of innovative skin patches, high demand for remote patient monitoring, an emerging trend of digital tattoos, presence of supporting initiatives and reimbursement policies, and a growing number of start-ups developing electronic skin patches.
  • Electronic skin patches anchor a device on the patient's or user's skin to achieve a specific function. These patches are attached to a user's skin and incorporated with sensors, actuators, processors, and communication technology, which allow the device to connect to the internet and turn it smart. Several significant application areas are now profoundly impacting health and quality of life. In particular, cardiovascular monitoring and diabetes management has been growing exponentially to create billions of annual revenues.
  • Electronic skin patches are one of the latest waves in health monitoring; their non-intrusive design means they are comfortable and discrete. These patches include sweat, axillary temperature, motion, biopotential (TENS, EMS) patches, and devices across various sectors and product categories. In cardiovascular monitoring, these devices range from traditional ECG options and monitoring devices for inpatients and outpatients to specific products such as Holter monitors, mobile cardiac telemetry devices, and other event monitors.

MARKET TRENDS & OPPORTUNITIES

Growing Number of Start-ups and Rise in the Development of Innovative Skin Patches

  • With the growing demand for technological innovations in the healthcare field, several start-ups are emerging to stay ahead of the technology curve to strengthen their competitive advantage in the electronic skin patches market. A few interesting start-ups and universities are working to bring advanced electronic skin sensor patches into the market. For instance, XSENSIO SA has developed next-generation wearable devices to track biochemical information on the wearer's skin surface. Scientists at the Georgia Institute of Technology have developed wireless wearable devices for measuring heart rate, electrocardiogram, respiratory rate, and motion activity. Some scientists have also developed a flexible, wearable patch detecting blood-alcohol levels from the user's sweat.

High Need for Constant Physiological Monitoring and Treatment for Hospitalized Patients

  • The growing burden of acute or chronic conditions has increased the need for continuous monitoring of both inpatients and outpatients. The major causes of death worldwide are due to heart diseases, cancers, diabetes, chronic lower respiratory syndrome, stroke, cerebrovascular diseases, viral infections, and others. Cardiovascular diseases are one of the leading causes of death worldwide, taking around 17.9 million lives each year. This increased the number of patients needing to constantly monitor heart rate, pulse rate, electrocardiogram, and other parameters related to the heart. The electronic skin patches market has emerged to monitor such physiological parameters for heart-related diseases and various other conditions.

Remote Patient Monitoring Driving the Adoption of Electronic Skin Patches

  • Remote patient monitoring uses innovative technology tools to collect and track patient data outside standard medical settings. With an increase in the prevalence of various diseases, many healthcare providers are shifting to implementing remote patient monitoring, especially in conditions such as elderly patients, pandemics, and others. The adoption of remote patient monitoring is increasing the use of electronic skin patches to transfer patient information directly to the healthcare provider or enter into the electronic medical records boosting the electronic skin patches market. Cardiology was one of the first therapy areas to introduce remote patient monitoring into standard practice. This sector streamlines doctor-hospital visits by remotely switching monitors between compact cardiac monitoring devices during the monitoring period.

Increase in Adoption of Healthcare Applications & Smart Wearables

  • Many users are increasingly adopting connected wearable medical devices due to their various advantages, such as continuous monitoring, prediction of health problems and providing alerts, a collection of detailed real-time longitudinal data, and helping educate and empower patients to take control of their health. These devices are being incorporated and connected to electronic skin patches, providing ease of use, and contributing to the growth of the global electronic skin patch market. Software applications in mobiles or smart watches are associated with these patches to send data directly and help monitor the users' health.

SEGMENTATION ANALYSIS

INSIGHTS BY APPLICATION

The global electronic skin patches market based on applications includes diabetes management, general patient monitoring, cardiovascular monitoring, and others. Diabetes management accounts for the highest share of 43.51% and is estimated to reach USD 18.10 billion by 2027 in the global market.

  • Diabetes Management: This includes electronic skin patches used to manage diabetes with continuous glucose monitoring and insulin pumps.
  • General Patient Monitoring: This includes electronic skin patches used to monitor various physiological parameters and majorly vitals such as temperature, heart rate, pulse rate, and respiratory rate.
  • Cardiovascular Monitoring: This includes electronic skin patches used in monitoring the activity of the heart by ECG, EKG, Holter monitoring, mobile cardiac telemetry, and ambulatory cardiac monitoring.
  • Others: This includes electronic skin patches used for various purposes such as cosmetics, sports, fitness & wellness, wound care, electrical stimulation, imaging, fetal monitoring, sleep tracking, stress, and pharmaceuticals.

Segmentation by Application

  • Home Care Settings
  • Hospitals
  • Physician Offices & Specialty Clinics
  • Others

INSIGHTS BY END-USER

Based on the end-user, the global electronic skin patches market includes home care settings, hospitals, physician offices & specialty clinics, and others. In 2021, home care settings accounted for the global market's highest share of 42.80%.

  • Home Care Settings: This includes home care providers and individuals using electronic skin patches to monitor and treat various conditions.
  • Hospitals: This includes hospitals that use electronic skin patches for monitoring and treating various conditions.
  • Physician Offices & Specialty Clinics: This includes physician offices & specialty clinics, diagnostic centers, sleep labs & clinics, and physiotherapy & rehabilitation centers that use electronic skin patches for monitoring and treating various conditions.
  • Others: This includes cosmetic clinics, sports, health and wellness centers, pharma & biotech companies, ambulatory surgical centers, and academic & research institutes that use electronic skin patches for monitoring and treating various conditions.

Segmentation by End-User

  • Home Care Settings
  • Hospitals
  • Physician Offices & Specialty Clinics
  • Others

GEOGRAPHICAL OVERVIEW

North America accounts for the highest share of 47.59% in the global electronic skin patches market. North America is the major revenue contributor in the global market due to various factors involved in its growth that including the rising prevalence of cardiac disorders and diabetes, the presence of advanced healthcare infrastructure, a rise of wearable devices for healthcare monitoring, a surge in the use of IoT based applications, miniaturization of sensors used in medical devices, a growing trend for maintaining personal health and fitness, and growing demand for skin patches for drug delivery.

Further, the U.S. accounts for 94.11% of North America's electronic skin patches market share. The growing demand for electronic skin patches across the country is likely growing with the rise in chronic conditions such as cardiovascular diseases and diabetes, which require constant monitoring of various parameters such as heart rate, blood glucose levels, blood pressure, and others. Due to this, most patients are using electronic skin patches that help monitor various physiological factors. For instance, in the U.S., for every 36 seconds, a person dies from cardiovascular disease. The increasing prevalence of various diseases is a significant factor contributing to the growing adoption of remote monitoring devices.

Europe has the second largest revenue share compared to other regions owing to the highly sophisticated healthcare infrastructure and high adoption and awareness of the advantages of electronic skin patches over conventional monitoring options. APAC is likely to be an emerging region in the global electronic skin patches market, with most people focusing on maintaining their physical health and continuously monitoring their physiological parameters. Latin America, the Middle East & Africa accounted for minimal shares in the global electronic skin patches market.

Segmentation by Geography

  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

COMPETITIVE LANDSCAPE

The competitive landscape in the global electronic skin patch market is currently intensifying due to the rapidly changing technological environment in the healthcare industry. Vendors operating the market are pursuing various strategies to provide the impetus for growth over the next few years.

These market participants adopt collaboration, partnerships, mergers, acquisitions, product launches, and other strategies. For instance, Philips acquired BioTelemetry, a leading player in the mobile cardiac telemetry market, in February 2021.

Large medical device companies are adopting an acquisition strategy to invest or partner with many emerging vendors to diversify their product portfolio and strengthen their presence in the overall market. For instance, iRhythm Technologies deployed ZioAT and ZioXT virtual platforms to help doctors treat a patient's heart using telemetry during the COVID-19 pandemic in April 2020.

The global electronic skin patches market is likely to get highly dynamic with the presence of major international, regional, and a handful of local vendors offering electronic skin patches. Abbott, Dexcom, General Electric Company, and Koninklijke Philips are vendors that contributed to a major share of the global electronic skin patches market.

Key Vendors

  • Abbott
  • Dexcom
  • General Electric Company
  • Koninklijke Philips N.V.

Other Prominent Vendors

  • Menarini Diagnostics
  • Bardy Diagnostics
  • Benware Medical
  • Bittium
  • Bloomlife
  • Blue Spark Technologies
  • BORSAM Biomedical Instruments
  • Boston Scientific
  • Cardiomo
  • DMS-Service
  • Epicore Biosystems
  • FUKUDA DENSHI
  • Gamastech
  • Holst Centre
  • Insulet
  • iRhythm Technologies
  • Isansys
  • LCR Hallcrest
  • LifeSignals
  • Liv ApS
  • Medicomp
  • Medidata
  • Medicsensors
  • Medtrum Technologies
  • Natures Frequencies
  • Nemaura Medical
  • OMRON Healthcare
  • Onera Technologies B.V.
  • PAINMASTER
  • QT Medical
  • Quad Industries
  • Smith+Nephew
  • SpotSee
  • The Surgical Company
  • Theranica Bio-Electronics
  • The Scott Fetzer Company
  • Virility Medical
  • VitalConnect
  • VivaLNK
  • Vivomi
  • WearOptimo
  • Xsensio

KEY QUESTIONS ANSWERED

  • 1. What is the expected growth of the global electronic skin patches market?
  • 2. What is the growth rate of the global electronic skin patches market?
  • 3. What are the latest trends in the global electronic skin patches market?
  • 4. Who are the key players in the global electronic skin patches market?
  • 5. Which region dominates the global electronic skin patches market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY APPLICATION
    • 4.3.2 MARKET SEGMENTATION BY END-USER
    • 4.3.3 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 GLOBAL ELECTRONIC SKIN PATCHES MARKET
    • 7.1.1 GROWING NUMBER OF STARTUPS & INNOVATIVE SKIN PATCHES
    • 7.1.2 HIGH NEED FOR CONSTANT PHYSIOLOGICAL MONITORING & TREATMENT FOR HOSPITALIZED PATIENTS
    • 7.1.3 REMOTE PATIENT MONITORING DRIVING ADOPTION OF ELECTRONIC SKIN PATCHES
    • 7.1.4 INCREASE IN ADOPTION OF HEALTHCARE APPLICATIONS & SMART WEARABLES
    • 7.1.5 MARKET SEGMENTATION OF GLOBAL ELECTRONIC SKIN PATCHES MARKET
    • 7.1.6 COMPETITIVE LANDSCAPE

8 INTRODUCTION

  • 8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 INCREASING START-UPS & UNIVERSITIES DEVELOPING E-SKIN PATCHES
  • 9.2 RISE OF INNOVATIVE ELECTRONIC SKIN PATCHES
  • 9.3 EMERGING TREND OF USING DIGITAL TATTOOS FOR HEALTH MONITORING
  • 9.4 HIGH DEMAND FOR REMOTE PATIENT MONITORING

10 MARKET GROWTH ENABLERS

  • 10.1 RISING NEED FOR CONTINUOUS PHYSIOLOGICAL MONITORING & TREATMENT
  • 10.2 PRESENCE OF SUPPORTING INITIATIVES, REGULATIONS & REIMBURSEMENT POLICIES
  • 10.3 INCREASING PENETRATION OF WEARABLE DEVICES & MOBILE HEALTHCARE PLATFORMS
  • 10.4 RISE IN USAGE OF ELECTRONIC SKIN PATCHES FOR DRUG DELIVERY & COSMETICS

11 MARKET GROWTH RESTRAINTS

  • 11.1 LIMITATIONS ASSOCIATED WITH USE OF ELECTRONIC SKIN PATCHES
  • 11.2 DATA SECURITY & PRIVACY ISSUES WITH E-SKIN PATCHES
  • 11.3 HIGH COST OF VARIOUS ELECTRONIC SKIN PATCHES

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY APPLICATION
    • 12.2.2 INSIGHTS BY END-USER
    • 12.2.3 INSIGHTS BY GEOGRAPHY
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 APPLICATION

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 DIABETES MANAGEMENT
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 DIABETES MANAGEMENT: MARKET BY GEOGRAPHY
  • 13.4 GENERAL PATIENT MONITORING
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 GENERAL PATIENT MONITORING: MARKET BY GEOGRAPHY
  • 13.5 CARDIOVASCULAR MONITORING
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 CARDIOVASCULAR MONITORING: MARKET BY GEOGRAPHY
  • 13.6 OTHERS
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 OTHERS: MARKET BY GEOGRAPHY

14 END-USER

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 HOME CARE SETTINGS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 HOME CARE SETTINGS: MARKET BY GEOGRAPHY
  • 14.4 HOSPITALS
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 HOSPITALS: MARKET BY GEOGRAPHY
  • 14.5 PHYSICIAN OFFICES & SPECIALTY CLINICS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 PHYSICIAN OFFICES & SPECIALTY CLINICS: MARKET BY GEOGRAPHY
  • 14.6 OTHERS
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 OTHERS: MARKET BY GEOGRAPHY

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
    • 16.2.1 NORTH AMERICA: APPLICATION
    • 16.2.2 NORTH AMERICA: END-USER
  • 16.3 KEY COUNTRIES
    • 16.3.1 US: MARKET SIZE & FORECAST
    • 16.3.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
    • 17.2.1 EUROPE: APPLICATION
    • 17.2.2 EUROPE: END-USER
  • 17.3 KEY COUNTRIES
    • 17.3.1 GERMANY: MARKET SIZE & FORECAST
    • 17.3.2 FRANCE: MARKET SIZE & FORECAST
    • 17.3.3 UK: MARKET SIZE & FORECAST
    • 17.3.4 ITALY: MARKET SIZE & FORECAST
    • 17.3.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 APAC: APPLICATION
    • 18.2.2 APAC: END-USER
  • 18.3 KEY COUNTRIES
    • 18.3.1 JAPAN: MARKET SIZE & FORECAST
    • 18.3.2 CHINA: MARKET SIZE & FORECAST
    • 18.3.3 INDIA: MARKET SIZE & FORECAST
    • 18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 18.3.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 LATIN AMERICA: APPLICATION
    • 19.2.2 LATIN AMERICA: END-USER
  • 19.3 KEY COUNTRIES
    • 19.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 19.3.2 MEXICO: MARKET SIZE & FORECAST
    • 19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 MIDDLE EAST & AFRICA: APPLICATION
    • 20.2.2 MIDDLE EAST & AFRICA: END-USERS
  • 20.3 KEY COUNTRIES
    • 20.3.1 TURKEY: MARKET SIZE & FORECAST
    • 20.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 20.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW
  • 21.2 MARKET SHARE ANALYSIS
    • 21.2.1 ABBOTT IN ELECTRONIC SKIN PATCHES MARKET
    • 21.2.2 DEXCOM IN ELECTRONIC SKIN PATCHES MARKET
    • 21.2.3 GENERAL ELECTRIC COMPANY IN ELECTRONIC SKIN PATCHES MARKET
    • 21.2.4 KONINKLIJKE PHILIPS N.V IN ELECTRONIC SKIN PATCHES MARKET

22 KEY COMPANY PROFILES

  • 22.1 ABBOTT
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 ABBOTT IN ELECTRONIC SKIN PATCHES MARKET
    • 22.1.3 PRODUCT OFFERINGS
    • 22.1.4 KEY STRATEGIES
    • 22.1.5 KEY STRENGTHS
    • 22.1.6 KEY OPPORTUNITIES
  • 22.2 DEXCOM
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 DEXCOM IN ELECTRONIC SKIN PATCHES MARKET
    • 22.2.3 PRODUCT OFFERINGS
    • 22.2.4 KEY STRATEGIES
    • 22.2.5 KEY STRENGTHS
    • 22.2.6 KEY OPPORTUNITIES
  • 22.3 GENERAL ELECTRIC COMPANY
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 GENERAL ELECTRIC COMPANY IN ELECTRONIC SKIN PATCHES MARKET
    • 22.3.3 PRODUCT OFFERINGS
    • 22.3.4 KEY STRATEGIES
    • 22.3.5 KEY STRENGTHS
    • 22.3.6 KEY OPPORTUNITIES
  • 22.4 KONINKLIJKE PHILIPS N.V.
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 KONINKLIJKE PHILIPS N.V. IN ELECTRONIC SKIN PATCHES MARKET
    • 22.4.3 PRODUCT OFFERINGS
    • 22.4.4 KEY STRATEGIES
    • 22.4.5 KEY STRENGTHS
    • 22.4.6 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

  • 23.1 A. MENARINI DIAGNOSTICS
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
  • 23.2 BARDY DIAGNOSTICS
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
  • 23.3 BENWARE MEDICAL
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
  • 23.4 BITTIUM
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 PRODUCT OFFERINGS
  • 23.5 BLOOMLIFE
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 PRODUCT OFFERINGS
  • 23.6 BLUE SPARK TECHNOLOGIES
    • 23.6.1 BUSINESS OVERVIEW
    • 23.6.2 PRODUCT OFFERINGS
  • 23.7 BORSAM BIOMEDICAL INSTRUMENTS CO.
    • 23.7.1 BUSINESS OVERVIEW
    • 23.7.2 PRODUCT OFFERINGS
  • 23.8 BOSTON SCIENTIFIC
    • 23.8.1 BUSINESS OVERVIEW
    • 23.8.2 PRODUCT OFFERINGS
  • 23.9 CARDIOMO
    • 23.9.1 BUSINESS OVERVIEW
    • 23.9.2 PRODUCT OFFERINGS
  • 23.10 DMS-SERVICE
    • 23.10.1 BUSINESS OVERVIEW
    • 23.10.2 PRODUCT OFFERINGS
  • 23.11 EPICORE BIOSYSTEMS
    • 23.11.1 BUSINESS OVERVIEW
    • 23.11.2 PRODUCT OFFERINGS
  • 23.12 FUKUDA DENSHI
    • 23.12.1 BUSINESS OVERVIEW
    • 23.12.2 PRODUCT OFFERINGS
  • 23.13 GAMASTECH
    • 23.13.1 BUSINESS OVERVIEW
    • 23.13.2 PRODUCT OFFERINGS
  • 23.14 HOLST CENTRE
    • 23.14.1 BUSINESS OVERVIEW
    • 23.14.2 PRODUCT OFFERINGS
  • 23.15 INSULET
    • 23.15.1 BUSINESS OVERVIEW
    • 23.15.2 PRODUCT OFFERINGS
  • 23.16 IRHYTHM TECHNOLOGIES
    • 23.16.1 BUSINESS OVERVIEW
    • 23.16.2 PRODUCT OFFERINGS
  • 23.17 ISANSYS
    • 23.17.1 BUSINESS OVERVIEW
    • 23.17.2 PRODUCT OFFERINGS
  • 23.18 LCR HALLCREST
    • 23.18.1 BUSINESS OVERVIEW
    • 23.18.2 PRODUCT OFFERINGS
  • 23.19 LIFESIGNALS
    • 23.19.1 BUSINESS OVERVIEW
    • 23.19.2 PRODUCT OFFERINGS
  • 23.20 LIV APS
    • 23.20.1 BUSINESS OVERVIEW
    • 23.20.2 PRODUCT OFFERINGS
  • 23.21 MEDICOMP
    • 23.21.1 BUSINESS OVERVIEW
    • 23.21.2 PRODUCT OFFERINGS
  • 23.22 MEDIDATA
    • 23.22.1 BUSINESS OVERVIEW
    • 23.22.2 PRODUCT OFFERINGS
  • 23.23 MEDICSENSORS S.L
    • 23.23.1 BUSINESS OVERVIEW
    • 23.23.2 PRODUCT OFFERINGS
  • 23.24 MEDTRUM TECHNOLOGIES
    • 23.24.1 BUSINESS OVERVIEW
    • 23.24.2 PRODUCT OFFERINGS
  • 23.25 NATURES FREQUENCIES
    • 23.25.1 BUSINESS OVERVIEW
    • 23.25.2 PRODUCT OFFERINGS
  • 23.26 NEMURA MEDICAL
    • 23.26.1 BUSINESS OVERVIEW
    • 23.26.2 PRODUCT OFFERINGS
  • 23.27 OMRON HEALTHCARE
    • 23.27.1 BUSINESS OVERVIEW
    • 23.27.2 PRODUCT OFFERINGS
  • 23.28 ONERA TECHNOLOGIES B.V.
    • 23.28.1 BUSINESS OVERVIEW
    • 23.28.2 PRODUCT OFFERINGS
  • 23.29 PAINMASTER
    • 23.29.1 BUSINESS OVERVIEW
    • 23.29.2 PRODUCT OFFERINGS
  • 23.30 QT MEDICAL
    • 23.30.1 BUSINESS OVERVIEW
    • 23.30.2 PRODUCT OFFERINGS
  • 23.31 QUAD INDUSTRIES
    • 23.31.1 BUSINESS OVERVIEW
    • 23.31.2 PRODUCT OFFERINGS
  • 23.32 SMITH+NEPHEW
    • 23.32.1 BUSINESS OVERVIEW
    • 23.32.2 PRODUCT OFFERINGS
  • 23.33 SPOTSEE
    • 23.33.1 BUSINESS OVERVIEW
    • 23.33.2 PRODUCT OFFERINGS
  • 23.34 THE SURGICAL COMPANY
    • 23.34.1 BUSINESS OVERVIEW
    • 23.34.2 PRODUCT OFFERINGS
  • 23.35 THERANICA BIO-ELECTRONICS
    • 23.35.1 BUSINESS OVERVIEW
    • 23.35.2 PRODUCT OFFERINGS
  • 23.36 THE SCOTT FETZER COMPANY
    • 23.36.1 BUSINESS OVERVIEW
    • 23.36.2 PRODUCT OFFERINGS
  • 23.37 VIRILITY MEDICAL
    • 23.37.1 BUSINESS OVERVIEW
    • 23.37.2 PRODUCT OFFERINGS
  • 23.38 VITAL CONNECT
    • 23.38.1 BUSINESS OVERVIEW
    • 23.38.2 PRODUCT OFFERINGS
  • 23.39 VIVALNK
    • 23.39.1 BUSINESS OVERVIEW
    • 23.39.2 PRODUCT OFFERINGS
  • 23.40 VIVOMI
    • 23.40.1 BUSINESS OVERVIEW
    • 23.40.2 PRODUCT OFFERINGS
  • 23.41 WEAROPTIMO
    • 23.41.1 BUSINESS OVERVIEW
    • 23.41.2 PRODUCT OFFERINGS
  • 23.42 XSENSIO
    • 23.42.1 BUSINESS OVERVIEW
    • 23.42.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

  • 24.1 KEY TAKEAWAYS
  • 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

  • 25.1 MARKET BY APPLICATION
    • 25.1.1 NORTH AMERICA: APPLICATION SEGMENTATION
    • 25.1.2 EUROPE: APPLICATION SEGMENTATION
    • 25.1.3 APAC: APPLICATION SEGMENTATION
    • 25.1.4 LATIN AMERICA: APPLICATION SEGMENTATION
    • 25.1.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
  • 25.2 MARKET BY END-USER
    • 25.2.1 NORTH AMERICA: END-USER SEGMENTATION
    • 25.2.2 EUROPE: END-USER SEGMENTATION
    • 25.2.3 APAC: END-USER SEGMENTATION
    • 25.2.4 LATIN AMERICA: END-USER SEGMENTATION
    • 25.2.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
  • 25.3 MARKET BY GEOGRAPHY
    • 25.3.1 DIABETES MANAGEMENT: GEOGRAPHY SEGMENTATION
    • 25.3.2 GENERAL PATIENT MONITORING: GEOGRAPHY SEGMENTATION
    • 25.3.3 CARDIOVASCULAR MONITORING: GEOGRAPHY SEGMENTATION
    • 25.3.4 OTHERS APPLICATIONS: GEOGRAPHY SEGMENTATION
    • 25.3.5 HOME CARE SETTINGS: GEOGRAPHY SEGMENTATION
    • 25.3.6 HOSPITALS: GEOGRAPHY SEGMENTATION
    • 25.3.7 PHYSICIAN OFFICES & SPECIALTY CLINICS: GEOGRAPHY SEGMENTATION
    • 25.3.8 OTHER END-USERS: GEOGRAPHY SEGMENTATION

26 APPENDIX

  • 26.1 ABBREVIATIONS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제